support_agent

Your contact persons

CHEPLAPHARM Arzneimittel GmbH

View:
format_list_bulleted grid_view

12/02/2015

CHEPLAPHARM assumes Italian rights for ALDACTONE®

CHEPLAPHARM acquired the product rights for the prescription medication ALDACTONE® in Italy on 09.11.2015, thus boosting its presence within this market that is very important to CHEPLAPHARM.


Archive
Read more chevron_right

12/01/2015

CHEPLAPHARM moves into new 2500 square meter office building at Greifswald’s Business Park Ziegelhof
Archive
Read more chevron_right

03/05/2015

CHEPLAPHARM Arzneimittel GmbH launches 100 million EURO investment program
Archive
Read more chevron_right

01/15/2014

CHEPLAPHARM continues its rapid growth: 50% sales increase in 2013 compared to the previous year.
Archive Press releases
Read more chevron_right

12/31/2012

CHEPLAPHARM acquires the rights for VESANOID® and ROHYPNOL® - largest investment since company´s existence.
Archive
Read more chevron_right

09/01/2010

CHEPLAPHARM attains the rights for HEMINEVRIN®/DISTRANEURIN®
Archive
Read more chevron_right
Back to top expand_less